Biocryst Pharmaceuticals Inc’s recent filing unveils that its Director Hutson Nancy J unloaded Company’s shares for reported $52780.0 on Dec 13 ’24. In the deal valued at $7.54 per share,7,000 shares were sold. As a result of this transaction, Hutson Nancy J now holds 86,638 shares worth roughly $0.97 million.
Then, Hutson Nancy J bought 7,000 shares, generating $52,584 in total proceeds.
Before that, McKee Amy E sold 8,600 shares. Biocryst Pharmaceuticals Inc shares valued at $54,352 were divested by the Director at a price of $6.32 per share. As a result of the transaction, McKee Amy E now holds 27,831 shares, worth roughly $0.31 million.
Cantor Fitzgerald initiated its Biocryst Pharmaceuticals Inc [BCRX] rating to an Overweight in a research note published on April 29, 2025; the price target was $20. A number of analysts have revised their coverage, including Wedbush’s analysts, who began to cover the stock in late February with a ‘”an Outperform”‘ rating. RBC Capital Mkts revised its rating on September 18, 2023. It rated BCRX as “an Outperform” which previously was an “a Sector perform”.
Price Performance Review of BCRX
On Tuesday, Biocryst Pharmaceuticals Inc [NASDAQ:BCRX] saw its stock jump 4.29% to $11.19. Over the last five days, the stock has gained 3.71%. Biocryst Pharmaceuticals Inc shares have risen nearly 48.80% since the year began. Nevertheless, the stocks have risen 70.32% over the past one year. While a 52-week high of $11.15 was reached on 06/03/25, a 52-week low of $5.92 was recorded on 04/10/25. SMA at 50 days reached $8.80, while 200 days put it at $8.09.
Levels Of Support And Resistance For BCRX Stock
The 24-hour chart illustrates a support level at 10.72, which if violated will result in even more drops to 10.25. On the upside, there is a resistance level at 11.45. A further resistance level may holdings at 11.71. The Relative Strength Index (RSI) on the 14-day chart is 68.49, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 0.39, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bullish at 3.40%. Stochastics %K at 81.31% indicates the stock is a selling.
How much short interest is there in Biocryst Pharmaceuticals Inc?
A steep rise in short interest was recorded in Biocryst Pharmaceuticals Inc stocks on 2025-05-15, growing by 0.54 million shares to a total of 20.98 million shares. Yahoo Finance data shows the prior-month short interest on 2025-04-15 was 20.44 million shares. There was a rise of 2.57%, which implies that there is a positive sentiment for the stock.
